Key facts
- Notable investors include Lapam Capital, Anhui Provincial Emerging Industry Investment, Taihe County State-owned Assets Investment Holding Group, Hubei Renxi Science and Technology Innovation Industry Investment Private Equity Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Shuobai Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Shuobai Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shuobai Pharmaceutical
Manufacturer of innovative chemical drugs intended to advance therapies for respiratory and oncological diseases. The company offers small-molecule drug pipelines, inhalation therapy expertise, and anti-tumor research, enabling healthcare providers and patients to have improved access to targeted therapies that enhance treatment outcomes.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2016
- Website
- showby-bj.com/
- Ownership
- Privately Held (backing)
Shuobai Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shuobai Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shuobai Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.